Kenneth Williams - Medican Enterprises Chairman and CEO
Chairman
Mr. Kenneth Williams serves as Chairman of the Board, Chief Executive Officer of the Company. He was Secretary of the Company. He was Chief Executive Officer of Medican Enterprises, Inc. He has over eighteen years of work experience in information technology, security and network engineering since 2015.
| Age | 42 |
| Tenure | 9 years |
| Phone | 800-416-8802 |
| Web | https://www.medicaninc.com |
Medican Enterprises Management Efficiency
The company has return on total asset (ROA) of (68.1839) % which means that it has lost $68.1839 on every $100 spent on assets. This is way below average. Medican Enterprises' management efficiency ratios could be used to measure how well Medican Enterprises manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CHAIRMAN Age | ||
| Eric Weisblum | Silo Pharma | 54 | |
| Garo Armen | Protagenic Therapeutics | 71 | |
Management Performance
| Return On Asset | -68.18 |
Medican Enterprises Leadership Team
Elected by the shareholders, the Medican Enterprises' board of directors comprises two types of representatives: Medican Enterprises inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medican. The board's role is to monitor Medican Enterprises' management team and ensure that shareholders' interests are well served. Medican Enterprises' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medican Enterprises' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kenneth Williams, Chairman and CEO | ||
| Kelvin Lindsey, CEO Director | ||
| Michael Thompson, Independent Director | ||
| Wayne Hansen, CFO | ||
| Kris Klassen, President |
Medican Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Medican Enterprises a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -68.18 | |||
| Current Valuation | 7.77 M | |||
| Shares Outstanding | 134.8 M | |||
| Shares Owned By Institutions | 0.52 % | |||
| Price To Sales | 2.72 X | |||
| Net Income | (56.52 M) | |||
| Cash And Equivalents | 9.4 K | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (2.42) X | |||
| Cash Flow From Operations | (2.98 M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medican Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Medican Enterprises information on this page should be used as a complementary analysis to other Medican Enterprises' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Medican Pink Sheet analysis
When running Medican Enterprises' price analysis, check to measure Medican Enterprises' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medican Enterprises is operating at the current time. Most of Medican Enterprises' value examination focuses on studying past and present price action to predict the probability of Medican Enterprises' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medican Enterprises' price. Additionally, you may evaluate how the addition of Medican Enterprises to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |